|
| 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- Basic information |
Product Name: | 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- | Synonyms: | 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)-;tert-butyl (2S,4S)-4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate;4-Des((3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl)-4-hydroxy-N-(tert-butyl formate) Teneligliptin;Teneligliptin Impurity 7/Teneligliptin Impurity C;(2S,4S)-tert-butyl 4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate | CAS: | 401564-34-9 | MF: | C13H22N2O4S | MW: | 302.39 | EINECS: | | Product Categories: | | Mol File: | 401564-34-9.mol | |
| 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- Chemical Properties |
| 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- Usage And Synthesis |
Uses | 4-Des((3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl)-4-hydroxy-N-(tert-butyl formate) Teneligliptin is a possible impurity of Teneligliptin (T018295), a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion, and has a half-life of 24.2 hours in the human body. |
| 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- Preparation Products And Raw materials |
|